EAST LANSING, Mich. — A new study analyzing the previous math standards of each state provides strong support for adoption of common standards, which U.S. students desperately need to keep pace with their counterparts around the globe, a Michigan State University scholar argues.
Forty-six states are implementing the Common Core math and reading standards, which nonetheless have come under fire recently by some researchers and would-be politicians.
DURHAM, N.C. – The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
CHAMPAIGN, Ill. — Adopting a loser-pays-all rule for criminal litigation would likely be feasible only if the rule applied to defendants who are wealthy, says a study from a University of Illinois law professor.
Nuno Garoupa, the H. Ross and Helen Workman Research Scholar in the College of Law, says a loser-pays-all rule could deter some crime when it's applied to either a corporation or an individual with deep pockets. But when defendants are not wealthy, such cost-shifting would be "wholly inappropriate," he says.
SALT LAKE CITY – Some heart attack patients end up back in the hospital just weeks after going home. It can happen for a variety of reasons, but doctors haven't had a reliable way to predict which patients will return — until now.
Thanks to a new tool developed by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City, physicians now have a tool to help identify these patients. This will enable physicians to re-evaluate their treatment plans in the hopes of preventing future admissions.
CHICAGO – Even in men and women with an optimal cardiovascular disease (CVD) risk factor profile, the lifetime risk estimate for CVD is greater than 30 percent, and is more than 50 percent for men and women overall, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease. The study is being released early online to coincide with the American Heart Association's Scientific Sessions.
CHICAGO – In a study that involved more than 16,000 Hispanic/Latino men and women living in the United States, the prevalence of major cardiovascular disease (CVD) risk factors was high and varied markedly across different background groups; and those born in the U.S. were more likely to report a history of coronary heart disease and stroke and to have multiple CVD risk factors, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.
Oxide catalysts, typically formulated as powders, play an integral role in many chemical transformations, including cleaning wastewater, curbing tailpipe emissions, and synthesizing most consumer products.
Two daily doses of a probiotic lowered key cholesterol-bearing molecules in the blood as well as "bad" and total cholesterol, in a study presented at the American Heart Association's Scientific Sessions 2012.
Probiotics are live microorganisms (naturally occurring bacteria in the gut) thought to have beneficial effects; common sources are yogurt or dietary supplements.In previous studies, a formulation of the bacteria, known as Lactobacillus reuteri NCIMB 30242, has lowered blood levels of LDL or "bad" cholesterol.
Hispanics and Latinos living in the U.S. are highly likely to have several major cardiovascular disease risk factors, such as high cholesterol, high blood pressure, obesity, diabetes, and smoking, according to a new, large-scale study. Risks vary among the diverse Hispanic/Latino groups, but individuals who were born in the U.S. are more likely to have multiple risk factors.
The findings are reported in the Nov. 7 issue of JAMA.
The economic impact of a heart attack and other forms of acute coronary syndrome goes beyond the hospital to the home and workplace, according to research presented at the American Heart Association's Scientific Sessions 2012.
Men and women with acute coronary syndrome face additional economic burdens in lost time and income from work and possible inability to return to work, researchers said.
Acute coronary syndrome (ACS) is an umbrella term for situations in which blood supplied to the heart muscle is suddenly blocked. It includes heart attack and angina or chest pain.
Boulder, Colorado, USA - Throughout history, people have sought to understand how the world came to be and how it has changed over time. This curiosity has produced a rich legacy of science and philosophy and also influenced religion and theology. In the November 2012 issue of GSA Today, David Montgomery of the University of Washington examines the history of geology and of biblical views regarding Earth's origins.
Family members didn't give CPR for cardiac arrests as often as passers-by or friends in a Japanese study presented at the American Heart Association's Scientific Sessions 2012.
Cardiac arrest is the sudden loss of heart function, typically resulting from an abnormal heart rhythm that causes the heart to quiver erratically and stop pumping blood. According to the American Heart Association, effective bystander CPR provided immediately after sudden cardiac arrest can double or triple a victim's chance of survival.
In one of the largest and longest trials involving patients with kidney failure, a study led by an international team of researchers found that cinacalcet — a drug commonly prescribed to patients with kidney failure and a disturbance of bone and mineral metabolism known as secondary hyperparathyroidism — does not significantly reduce the risk of death or major cardiovascular events.
The results of the trial known as EVOLVE, which enrolled nearly 4,000 kidney patients from several continents and stretched over five years, were mixed, researchers said.
Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease.
SAN DIEGO -- A drug therapy shows promise for treating an inherited form of kidney disease called autosomal dominant polycystic kidney disease (ADPKD), Mayo Clinic researchers say. The medication, tolvaptan, slowed the pace of kidney cyst growth over the three years of the study. The phase three clinical trial results were being presented today at the American Society of Nephrology annual meeting and published online in the New England Journal of Medicine.